Satisfai Health, Inc. (“Satisfai”) and Virgo Surgical Video Solutions, Inc. (“Virgo”) today announced centralized readout, data collection and decision-making for disease-revolutionizing inflammatory bowel disease clinical trials announced a strategic partnership to provide assistance, and patient registry (IBD) and related GI conditions. Satisfai, a global leader in developing artificial intelligence solutions for gastroenterology, and Virgo, an industry leader in endoscopic video capture technology, have joined forces with leading gastroenterology CRO Alimentiv to Leverage your strengths and realize your full potential. Study of AI-assisted precision imaging in clinical gastrointestinal research.
“This synergy between Satisfai and Virgo with his Alimentiv is a positive development for IBD patients and the drug development field. It will significantly change the way the exam is administered.” “We are excited about this agreement to introduce next-generation imaging technology into gastroenterology clinical trials.”
“Artificial intelligence in medicine is being used increasingly in a variety of clinical specialties, with gastroenterology, particularly endoscopy, being an important application area. CEO and Founder of Satisfai Health, Vancouver Medical “We are excited to work with Virgo to bring AI-driven solutions to the IBD clinical trial space,” said Michael Byrne, clinical professor and gastroenterologist at Physics. Working with Alimentiv, a leading gastroenterology and imaging CRO, is a great opportunity.Our clear goal is to transform the clinical research paradigm for IBD and other disease states such as eosinophilic esophagitis. It’s about making a change, and I’m confident that with the three groups working together, we can make this happen.”
“The combination of Satisfai’s Marquis AI solution with Virgo’s HIPAA and SOC 2 compliant automated cloud video capture technology and Alimentiv’s 21CFR11 compliant solution, extensive site community and imaging expertise is very powerful. We are very excited to bring this vision to life and bring real-time, inline AI solutions to gastrointestinal clinical trials around the world,” said Matthew Schwartz, CEO and co-founder of Virgo.
The partnership continues his Alimentiv leadership in gastrointestinal clinical trials through exclusive access to Satisfai’s SmartScore Central Reading tool and Virgo’s fully integrated, hands-free, cloud-based, high-definition video capture fleet. promotes it. Additionally, pharma and biotech sponsors will have access to the ongoing development of new endpoints, scoring methods and scalable solutions designed to bring new therapies to market faster.